What’s New in Breast Cancer Care

Breast cancer treatment is evolving rapidly. Several promising advances from 2024 and 2025 are expanding options, especially for cases once considered hard to treat, and improving quality of life, progression-free survival, and overall survival for many.

Advances Worth Knowing About

♥ Targeted therapies that delay chemotherapy in common breast cancers
For people with hormone receptor positive (HR+), HER2-negative breast cancer carrying a PIK3CA mutation, a common mutation in this subtype, a new drug combination has delivered major results. Tests combining a targeted inhibitor (blocking the mutated PI3K protein) with other hormone therapies significantly extended how long patients lived overall, delayed disease progression, and allowed many to avoid or delay chemotherapy by almost two years. Institute of Cancer Research

What this may mean for you:

  • Some people can delay chemotherapy

  • Treatment can be more tailored to the tumour’s genetics

  • Side effects may be easier to manage than standard chemo

  • These treatments are often used when cancer has spread or returned

Always ask your clinician whether genetic testing of the tumour could guide your treatment.

♥ New oral hormone-receptor degrading drugs
Another promising development is in a new class of oral medications called SERDs or PROTAC based oestrogen-receptor degraders. In recent trials, these medications worked well in people whose cancers had developed resistance to traditional hormone treatments, helping to keep disease progression at bay longer and with manageable side-effects. biochempeg.com

What this may mean for you:

  • Treatment taken by mouth rather than by injection

  • Helpful when the cancer has become resistant to previous hormone therapy

  • Often combined with other medicines to keep the cancer under control longer

♥ More precise first-line therapy for aggressive HER2-positive cancers
For people with advanced HER2-positive breast cancer, a new combination regimen has shown much longer periods without disease progression compared with standard chemotherapy-based therapies. This means a better chance of maintaining quality of life while managing the disease. Breast Cancer.org

What this may mean for you:

  • Longer periods of stability

  • More personalised combinations instead of relying solely on chemotherapy

  • Potentially better quality of life during treatment

♥ Better tracking of tumour mutations with liquid biopsy
Doctors and researchers are increasingly using blood-based tests (liquid biopsies) to detect tumour DNA in the bloodstream. This allows them to spot emerging mutations early, sometimes even before the cancer visibly changes, and adjust therapies accordingly. It represents a step forward in personalising care and staying ahead of treatment resistance. Cancer Research UK - Cancer News

What this may mean for you:

  • Earlier warning signs if the cancer starts to change

  • More informed treatment decisions

  • A way to avoid unnecessary treatments if everything is stable

Why This Matters

For patients, these advances mean more tailored and less invasive treatment options. Targeted therapies and new oral drugs can reduce the need for harsh chemotherapy. More precise first-line treatments can offer better outcomes in aggressive cancers. Liquid biopsy enables closer monitoring and earlier intervention, potentially reducing relapse risk.

For communities and advocates (like us at The Pink Bob), this means renewed hope, a stronger toolbox to support people through treatment, recovery, and beyond.

Raising awareness about these options helps ensure people know to ask about them with their oncologists.

A gentle reminder

This guide is designed to help you feel informed, not overwhelmed.

Every breast cancer journey is different, and the best treatment plan is the one you build together with your oncology team.